Women’s Health Initiative
The Women's Health Initiative (WHI), sponsored by the National Heart, Lung, and Blood Institute (NHLBI), is a long-term national health study that focuses on strategies for preventing heart disease, breast and colorectal cancer, and osteoporosis in postmenopausal women. These chronic diseases are the major causes of death, disability, and frailty in older women of all races and backgrounds.
Goals
- To prevent heart disease, breast and colorectal cancer, and osteoporosis in postmenopausal women.
- To evaluate the effectiveness of hormone therapy, dietary changes, and calcium/vitamin D supplementation on these conditions.
- To understand the long-term health outcomes in women through extensive clinical trials and observational studies.
Sponsor
- Federal Agency: National Heart, Lung, and Blood Institute (NHLBI)
- Sponsoring Office: Part of the National Institutes of Health
Creation
The WHI was established in 1991 by the U.S. Congress through the National Institutes of Health Revitalization Act, which mandated research into conditions affecting women.
Funding
The WHI received an initial funding of $625 million for its first phase from 1993 to 2005. Funding has continued for extension studies, with allocations coming from the NIH budget.
Leadership
The program is managed by the Principal Investigator of the Women's Health Initiative, with multiple co-investigators involved due to the study's scope.
Website
https://www.nhlbi.nih.gov/science/womens-health-initiative-whi
Social Media Accounts
- No official social media accounts are listed for the WHI.
Wikipedia Article
wikipedia:Women's Health Initiative